Digest Réseau Comment ça marche
Digest / Communiqué

The Board of Directors of Fine Foods & Pharmaceuticals N.T.M. S.p.A. approved the Draft Financial Statements and Consolidated Financial Statements as of 31 December 2025

Compatibilité
Sauvegarder(0)
partager
The Board of Directors of Fine Foods & Pharmaceuticals N.T.M. S.p.A. approved the Draft Financial Statements and Consolidated Financial Statements as of 31 December 2025
Documents joints (1)

20094_164011_2026_oneinfo.pdf

Télécharger le dossier de presse ->
Coordonnées

Communiqués connexes

05/08/2025
Finance
Épargne/Affaires personnelles
Fonds d'investissement
Industrie
Growing revenue Adjusted EBITDA was €21.6 million, +35%, and margins for 16.8%
Source
Fine Foods & Pharmaceuticals N.T.M. S.p.A
Émetteur
1INFO
Découvrez les affinités
0
06/11/2025
Finance
Épargne/Affaires personnelles
Fonds d'investissement
Industrie
Fine Foods confirms growth trajectory: revenue +7%, Adjusted EBITDA was €30.5 million (+30.2%) and Adjusted EBITDA Margin 16.1%
Source
Fine Foods & Pharmaceuticals N.T.M. S.p.A
Émetteur
1INFO
Découvrez les affinités
0
13/03/2025
Finance
Épargne/Affaires personnelles
Fonds d'investissement
Industrie
The Board of Directors of Fine Foods & Pharmaceuticals N.T.M. S.p.A. today reviewed and approved the Draft Financial Statements and Consolidated Financial Statements as of 31 December 2024.
Source
Fine Foods & Pharmaceuticals N.T.M. S.p.A
Émetteur
1INFO
Découvrez les affinités
0